Hereditary Breast Cancer/ Genetic Counseling and Testing


Genetic Assessment of Breast and Ovarian Cancer Risk

OncLive, April 30, 2012.

Etiology and Clinical Features of Hereditary Breast and Ovarian Cancer (HBOC)

This educational module contains scientific and clinical features of Hereditary Breast and Ovarian Cancer, including clinical management.  The module is developed courtesy of Myriad Genetic Laboratories.

National Cancer Institutes' PDQ concerning Genetics of Breast and Ovarian Cancer

This PDQ from the NCI is an informative resource concerning clinical matters of inherited breast and ovarian cancer.

Testing My Children

Oncology Times, Volume 31, # 18, September 25, 2009, p. 18.  Author: Harpham, Wendy S.

Hereditary Breast Cancer

This educational module is provided by Myriad Genetic Laboratories to educate providers on the lifetime risk of cancer associated with inheritance of a BRCA mutation, associated with an increased risk of breast and ovarian cancer.

Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Journal of Clinical Oncology, Volume 31, # 25, pp. 3091-3099, September 1, 2013.  First author: Phillips, Kelly-Anne

Adjuvant Oophorectomy in the Treatment of Early-Stage BRCA Mutation Positive Breast Cancer

 This article in the clinical journal, JAMA Oncology 1(3),313, author: Disis, Mary L. reveals that women with a BRCA 1 mutation had improved survival with surgical removal of their ovaries, in certain circumstances.  Read more here: